A Phase 1 Safety and Intrapulmonary Pharmacokinetics Study of ZTI-01 (Intravenous Fosfomycin Disodium) in Healthy Adult Subjects
Phase of Trial: Phase I
Latest Information Update: 30 Oct 2019
Price : $35 *
At a glance
- Drugs Fosfomycin (Primary)
- Indications Bacterial infections; Nosocomial pneumonia; Pneumonia
- Focus Adverse reactions; Pharmacokinetics
- 24 Oct 2019 Planned End Date changed from 30 Sep 2019 to 30 Mar 2020.
- 24 Oct 2019 Planned primary completion date changed from 30 Sep 2019 to 30 Mar 2020.
- 13 Jun 2019 Status changed from not yet recruiting to recruiting.